viewElixinol Global Ltd

Elixinol Global 'only company in the sector to list a profit'

Elixinol Global Ltd (ASX:EXL) executive director & CEO Paul Benhaim speaks to Proactive Investors about the cannabis group of companies’ business sectors and suite of hemp-based foods, supplements and medicinal oil products.
The group’s portfolio comprises three main divisions: Elixinol USA focused on dietary supplements; Hemp Foods Australia selling food products; and Elixinol Australia, the new start-up focused on medicinal cannabis.
“Elixinol Global listed in January this year on the ASX and we did that to raise about $20 million which was a highly oversubscribed listing,” Benhaim says.
He continues, “those funds were intended to be used on the medical cannabis business start-up in Australia … that business has applied for licences with the Office of Drug  Control, which we’re currently waiting for.”
Recently announced half-year results show Elixinol Global grew over 110% on the prior period, with first-half revenue of $14.9 million.

Quick facts: Elixinol Global Ltd

Price: 0.245 AUD

Market: ASX
Market Cap: $40.33 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Thunderbird Entertainment sees strong third quarter results...

Thunderbird Entertainment (CVE: TBRD-OTC: THBRF) CEO Jennifer Twiner McCarron joined Steve Darling from Proactive Vancouver to share news the company has released their 3rd quarter financial numbers which saw a 40 per cent increase from Q-3 of last year. Twiner-McCarron talks about what led...

2 days, 14 hours ago

2 min read